praying for health in Changchun biological products co., Ltd. (hereinafter referred to as "praying for invigorating the biological") was established in December 2003, is located in the white mountain pine water between Changchun national high-tech development zone, covers an area of 30,000 square meters.

praying for invigorating the biological is the China national pharmaceutical group Corporation is a member of three-level high-tech enterprise, founded funded from the Changchun Institute of biological products. in September 2006, the company is a sound corporate governance structure, capital diversified, management standardization, in order to create conditions for the development, successfully achieved an equity restructuring, restructuring shareholder composition as: Beijing tiantan biological products co., Ltd. has cent of equity, Changchun Institute of biological products has 51% shares, China biotechnology group owns 10% shares.

praying for invigorating the biological existing staff of 229 people, professionals of 165 people, 72% per cent of total staff. praying for invigorating the biological product has two pillars: freeze-dried live attenuated varicella vaccine and measles vaccine. pray for invigorating the biological is the first domestic varicella vaccine, chickenpox vaccine to market new Trojan most enterprises, is the only domestic supplier of varicella vaccine exports. praying for invigorating the biological application is long-47 strain of measles vaccine attenuated measles vaccine strains, ratified in 1966 for vaccine production.2009 year, length-47 and purification of strains have been approved for production. this product can be provided for countries to enhance the measles vaccine strengthening immunization support.

in 2007, the company has invested nearly $ 200 million new new production bases, new factory covers an area of 23,732 square meters, construction area of 18,000 square meters, according to the new version of GMP requirements of design and construction, February 2010 through GMP certification and put into use, 8 million people with an annual output of varicella vaccine, measles vaccine capacity to 20 million people.

biological after seven years of praying for health management, initial total assets of $ 60 million, total assets at the end of 2010 to $ 333.0187 million, of which: 196.1912 million yuan in fixed assets, total assets 58.91%.2010 years after the reorganization of assets to achieve a faster development, advanced infrastructure, product quality is stable, maintained its market share in domestic varicella vaccine first. the average growth rate for 2007-2010 operating income 16.5%, average annual growth in net profit to 21.59%.
praying for health bio has been adhering to the "love life, caring for health" business philosophy. the company "Twelve-Five" during the reform spirit of continuous innovation, development planning with an open mind, as a new production base for the new starting point, strengthening the construction of quality guarantee system, capacity expansion, expansion and consolidation of the domestic and international market share, enable companies to achieve the goal of sustainable development.